AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS REVIEW

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS REVIEW

Amgen (AMGN) PT Raised to $280 at Jefferies

February 9, 2022 7:40 AM UTC

Jefferies analyst Michael Yee raised the price target on Amgen (NASDAQ: AMGN) to $280.00 (from $266.00) while maintaining a Buy rating.

The analyst commented, "Much can happen in a decade, but we built a calculator model to back into assumptions for 2030 (Ex 1). The... More